What this study is
This trial aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in peripheral neuropathy clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors.
Ultimately, this trial endeavors to deepen our understanding of the factors impacting peripheral neuropathy clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.
Study details
- Official title
- A Study of Peripheral Neuropathy Clinical Trial Experiences: Insights From Patients
- Sponsor
- Power Life Sciences Inc.
- Conditions
- Peripheral Neuropathy
- Enrolling
- 500 people
- Starts
- 2025-04
- Est. completion
- 2027-04
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Aged ≥ 18 years old
- Diagnosis of peripheral neuropathy
- Able to comprehend the investigational nature of the protocol and provide informed consent
You can't join if
- Female patients who are currently pregnant or nursing
- Inability to perform regular electronic reporting
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openPower Life Sciences
San Francisco, California, United States
- Michael B Gill · Contact415-900-4227https://www.withpower.com/contact-us@withpower.com
Study team
Sponsor
Power Life Sciences Inc.
Study ID 44735129
Study director
Michael B Gill
Power Life Sciences Inc.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.